-
Mashup Score: 0ASCO - 8 month(s) ago
Dear Colleagues,Many physicians have raised concerns about the current Maintenance of Certification (MOC) requirements administered by the American Board of Internal Medicine (ABIM). ASCO members are no exception, and we have heard widespread concern that the program, including the current Longitudinal Knowledge Assessment, is not supporting relevant learning and can be time-consuming and…
Source: m.email.asco.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 4ASCO - 1 year(s) ago
From the American Society of Clinical Oncology in cooperation with the Food and Drug Administration (FDA) and as a service to our members, ASCO will periodically distribute information about newly approved therapies for cancer patients. This helps FDA inform oncologists and professionals in oncology-related fields about recent approvals in a timely manner. Included in the email from the FDA will…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8ASCO - 1 year(s) ago
From the American Society of Clinical Oncology in cooperation with the Food and Drug Administration (FDA) and as a service to our members, ASCO will periodically distribute information about newly approved therapies for cancer patients. This helps FDA inform oncologists and professionals in oncology-related fields about recent approvals in a timely manner. Included in the email from the FDA will…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 36ASCO - 2 year(s) ago
From the American Society of Clinical Oncology in cooperation with the Food and Drug Administration (FDA) and as a service to our members, ASCO will periodically distribute information about newly approved therapies for cancer patients. This helps FDA inform oncologists and professionals in oncology-related fields about recent approvals in a timely manner. Included in the email from the FDA will…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2ASCO - 2 year(s) ago
View full prescribing information for Opdivo. This review was conducted under Project Orbis, an initiative of the FDA Oncology Center of Excellence. Project Orbis provides a framework for concurrent submission and review of oncology drugs among international partners. For this review, FDA collaborated with the Australian Therapeutic Goods Administration (TGA),…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1ASCO - 2 year(s) ago
More than 2,800 abstracts were accepted for presentation at the Annual Meeting, and more than 2,400 additional abstracts were accepted for online publication. The majority of these abstracts were publicly released on asco.org/abstracts today, Thursday, May 26, at 5:00 PM (ET). Late-Breaking Abstracts (LBAs), including Plenary abstracts, will be released at…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2ASCO - 2 year(s) ago
More than 2,800 abstracts were accepted for presentation at the Annual Meeting, and more than 2,400 additional abstracts were accepted for online publication. The majority of these abstracts were publicly released on asco.org/abstracts today, Thursday, May 26, at 5:00 PM (ET). Late-Breaking Abstracts (LBAs), including Plenary abstracts, will be released at…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10ASCO - 2 year(s) ago
…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 22ASCO - 2 year(s) ago
Studies presented in the Series will also be placed in a high-profile session for oral presentation at the 2022 ASCO Annual Meeting, taking place June 3-7. We look forward to you joining us at the premier global event in oncology to reconnect with old friends and colleagues, network, and collaborate while discovering the latest…
Source: m.email.asco.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RT @DrChoueiri: The abstracts for February @ASCO Plenary Series are here: https://t.co/CY07jLU6fT https://t.co/uNeVcqgGUB
-
-
Mashup Score: 2ASCO - 2 year(s) ago
ASCO will not be checking test results, but your attendance will be taken as confirmation that you are fully compliant with our rules. We appreciate everyone doing their part to help keep all attendees and the scientific community safe. Many communities have free COVID-19 testing available. Learn more about testing in your locality. Mask Requirements: All…
Source: m.email.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
Great initiative @ASCO . Thank you for hearing your members concerns!! @CliffordHudis @ASCOPres #proudmember https://t.co/bhounPtERE